XYZALL 5 mg, film-coated tablet 14 tablets
Active ingredients: Levocetirizine dihydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet14 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- XYZALL 5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) polyamide aluminium PVC-Aluminium de 14 comprimé(s)
- Marketing authorisation holder
- UCB PHARMA
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 25 Sept 2024
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66296411CIP73585024CIP133400935850249Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DICHLORHYDRATE DE LÉVOCÉTIRIZINEcomprimé | 5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: LEVOCETIRIZINE (DICHLORHYDRATE DE) 5 mg – XYZALL 5 mg, comprimé pelliculé.
